| Clinical Dilemmas and Problems in Assessing Prostatic Metastasis to Bone: The Scientific Challenge | p. 1 |
| Comparative Study of Prostatic Carcinoma Bone Metastasis among Japanese in Japan and Japanese Americans and Whites in Hawaii | p. 7 |
| Prostate Cancer in the United States and Japan | p. 17 |
| Analysis of Survival of Prostate Cancer Patients in Japan and the U.S.A. | p. 29 |
| The Cellular Basis for Prostate Cancer Metastasis | p. 39 |
| Cytogenetic and Molecular Genetic Aspects of Human Prostate Cancer: Primary and Metastatic | p. 45 |
| Hemodynamics of Prostate Bone Metastases | p. 77 |
| Role of the Vertebral Venous System in Metastatic Spread of Cancer Cells to the Bone | p. 83 |
| Clinical Significance of the Vertebral Vein in Prostate Cancer Metastasis | p. 93 |
| Effects of Various Growth Factors on a Chondrocyte Differentiation Model | p. 101 |
| Potential Role of HBGF (FGF) and TGF-Beta on Prostate Growth | p. 107 |
| Hormone Refractory Prostatic Cancer: The Role of Radiolabelled Diphosphonates and Growth Factor Inhibitors | p. 115 |
| Localization of Basic Fibroblast Growth Factor (bFGF) in a Metastatic Cell Line (AT-3) Established from the Dunning Prostatic Carcinoma of Rat: Application of a Specific Monoclonal Antibody | p. 131 |
| Use of a Reconstituted Basement Membrane to Study the Invasiveness of Tumor Cells | p. 141 |
| Animal Prostate Carcinoma Models: Limited Potential for Vertebral Metastasis | p. 151 |
| A Model for Studies on Human Prostatic Carcinoma | p. 159 |
| Studies on the Pathogenesis of Osteoblastic Metastases by Prostate Cancer | p. 165 |
| Analysis of Bone Metastasis of Prostatic Adenocarcinoma in 137 Autopsy Cases | p. 173 |
| Nucleolar Organizer Regions in Prostate Cancer | p. 183 |
| Flow Cytometric Analysis of Prostatic Carcinoma with and without Bone Marrow Metastasis | p. 189 |
| Evaluation of the Response of Bone Metastases to Therapy | p. 193 |
| Computed Tomographic Evaluation of Bone Metastases in Prostatic Cancer Patients | p. 197 |
| Magnetic Resonance Imaging of Bone Metastases | p. 205 |
| Bone Marrow MRI in Prostate Cancer | p. 209 |
| Bone Mineral Density for Patients with Bone Metastasis of Prostate Cancer: A Preliminary Report | p. 217 |
| Quantification of Changes in Bone Scans of Patients with Osseous Metastases of Prostatic Carcinoma | p. 233 |
| The Usefulness of Serum Acid Phosphatase in Monitoring Patients with Advanced Prostate Carcinoma | p. 245 |
| Radiation Treatment of Prostate Bone Metastases and the Biological Considerations | p. 255 |
| Clinical Course of Bone Metastasis from Prostatic Cancer Following Endocrine Therapy: Examination with Bone X-Ray | p. 269 |
| Palliative Radiotherapy of Bone Metastasis | p. 277 |
| Clinical Study of Bone-Related Relapse in Prostate Carcinoma | p. 283 |
| Surgical Treatment of Metastatic Tumors of Long Bones and the Spine | p. 295 |
| Hormone Therapy of Prostatic Bone Metastases | p. 305 |
| Index | p. 317 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
